Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine.
Saved in:
| Title: | Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine. |
|---|---|
| Authors: | Seyed N; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran., Taheri T; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran., Vauchy C; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France., Dosset M; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France., Godet Y; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France., Eslamifar A; Department of Electron Microscopy and Clinical Research, Pasteur Institute of Iran, Tehran, Iran., Sharifi I; School of Medicine, Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran., Adotevi O; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service d'Oncologie, Besançon, France., Borg C; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service d'Oncologie, Besançon, France., Rohrlich PS; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service de pédiatrie, Besançon, France., Rafati S; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran. |
| Source: | PloS one [PLoS One] 2014 Oct 13; Vol. 9 (10), pp. e108848. Date of Electronic Publication: 2014 Oct 13 (Print Publication: 2014). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25310094 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Seyed+N%22">Seyed N</searchLink>; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Taheri+T%22">Taheri T</searchLink>; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Vauchy+C%22">Vauchy C</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Godet+Y%22">Godet Y</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Eslamifar+A%22">Eslamifar A</searchLink>; Department of Electron Microscopy and Clinical Research, Pasteur Institute of Iran, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Sharifi+I%22">Sharifi I</searchLink>; School of Medicine, Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.<br /><searchLink fieldCode="AU" term="%22Adotevi+O%22">Adotevi O</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service d'Oncologie, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Borg+C%22">Borg C</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service d'Oncologie, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Rohrlich+PS%22">Rohrlich PS</searchLink>; INSERM U1098, Unité Mixte de Recherche, Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté, Besançon, France; Université de Franche-Comté, Besançon, France; CHRU de Besançon, Service de pédiatrie, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Rafati+S%22">Rafati S</searchLink>; Molecular Immunology and Vaccine Research Lab, Pasteur Institute of Iran, Tehran, Iran. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2014 Oct 13; Vol. 9 (10), pp. e108848. <i>Date of Electronic Publication: </i>2014 Oct 13 (<i>Print Publication: </i>2014). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25310094 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0108848 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e108848 Titles: – TitleFull: Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Seyed N – PersonEntity: Name: NameFull: Taheri T – PersonEntity: Name: NameFull: Vauchy C – PersonEntity: Name: NameFull: Dosset M – PersonEntity: Name: NameFull: Godet Y – PersonEntity: Name: NameFull: Eslamifar A – PersonEntity: Name: NameFull: Sharifi I – PersonEntity: Name: NameFull: Adotevi O – PersonEntity: Name: NameFull: Borg C – PersonEntity: Name: NameFull: Rohrlich PS – PersonEntity: Name: NameFull: Rafati S IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 10 Text: 2014 Oct 13 Type: published Y: 2014 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 9 – Type: issue Value: 10 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
